CSL · CSL Limited

192.20

AUD

5.30 (2.84%)

16/10/2026 04:10:06 PM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$88.58B

15.30

EV/EBITDA

9.5

DIV Yield

3.5%

Franking

0%

MQV Rating

4Weak

As at 16/10/2026 04:10:06 PM

Price Chart

Description

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

All-Companies
All-Consensus
ALL-Recommendations
ASR Trading Report - All
EMA 125 Breakup
Fakey Shakey - Short
Fakey Shakey - Short (Realtime)
GROWTH AUS
HALO 100
HALO 200
HALO 50
HALO Growth
HALO Ords
HALO Price Momentum
Hammer Bullish
Near Resistance
Near Resistance (Realtime)
Recent Price upgrade

Key Fundamentals

EPS 3 yr Growth

-215.00%

EBITDA Margin

32.20%

Operating Cashflow

$3,512m

Free Cash Flow Return

12.80%

ROIC

-9.40%

Interest Coverage

11.70

Quick Ratio

1.00

Performance

52 weeks range

Low 90 - 222.47

Trade Value (12mth)

US$35,722,328.00

1 week

1.43%

1 month

5.84%

YTD

7.34%

1 year

-15.19%

All time high

342.75

Additional Data

Shares Outstanding (Fully Diluted)

479m

HALO Sector

Healthcare

Next Company Report Date

17-Aug-27

Next Ex Dividend Date

09-Sep-26

Next Dividend Pay Date

02-Oct-26

Reporting Currency

USD

Short Sell (% of issue)

1.09

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Strong

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Strong

Dividends

Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Weak

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

Date	Event
08 October 26ASXD
07 October 26ASXD
05 October 26ASXD
24 September 26ASXD
23 September 26ASXD

Key Stakeholders

Name	Title
Brian Anthony McNamee	Individual
Gordon Naylor	Individual
Robert Andrew Cuthbertson	Individual
Paul McKenzie	Individual
Alison Mary Watkins	Individual